Shared on 04 Nov 25

Analysts have maintained their fair value estimate for Ramsay Health Care at $37.23 per share. They cite stable growth and profitability projections, even though there has been a slight decrease in the discount rate used in their valuation models.

Shared on 21 Oct 25

Fair value Decreased 2.30%

The analyst price target for Ramsay Health Care has been revised downward from $38.11 to $37.23. This change reflects adjustments in analysts' expectations for key financial metrics, including slightly higher revenue growth and profit margin, offset by a higher discount rate and a reduced forward P/E ratio.

Shared on 29 Aug 25

Fair value Decreased 7.74%

Ramsay Health Care’s fair value has been revised downward as weakening net profit margins and a higher future P/E ratio have raised concerns over earnings growth and valuation, reducing the consensus analyst price target from A$41.31 to A$38.56. Valuation Changes Summary of Valuation Changes for Ramsay Health Care The Consensus Analyst Price Target has fallen from A$41.31 to A$38.56.